AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Editas Medicine, Inc. Director's Dealing 2021

Jun 16, 2021

33260_dirs_2021-06-16_513c6739-8db9-450b-a903-9ebef6f25518.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Editas Medicine, Inc. (EDIT)
CIK: 0001650664
Period of Report: 2021-06-14

Reporting Person: Shearman Mark S (EVP, Chief Scientific Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
No securities are beneficially owned	0	Direct